跳至主要内容
临床试验/TCTR20230307001
TCTR20230307001Unknown2 期

The Preliminary Results of the Comparison between Olanzapine and One-Dose Dexamethasone and Four-Day Dexamethasone in Prevention of Chemotherapy induced Nausea and Vomiting in Patients with Pancreatic Cancer Receiving Modified FOLFIRINOX

Hathaipat Veerawatananan0 个研究点目标入组 14 人开始时间: 2023年3月7日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Eligible patients were 18 and 80 years old patients with Eastern Cooperative Oncology group (ECOG) performance status 0-1

排除标准

  • preexisting nausea symptoms, inadequate organ function, allergy or contraindication to ondansetron, dexamethasone, olanzapine, cognitive compromise or having a history of dyskinesia, movement, CNS disorder or psychiatric disorder

研究者

发起方
Hathaipat Veerawatananan

相似试验